Quinazolinone derivatives as tubulin polymerization inhibitors

Details for Australian Patent Application No. 2009228945 (hide)

Owner Janssen Pharmaceutica NV

Inventors Meyer, Christophe; Freyne, Eddy Jean Edgard; Bourdrez, Xavier Marc; Pasquier, Elisabeth Therese Jeanne; Mevellec, Laurence Anne; Angibaud, Patrick Rene; Vialard, Jorge Eduardo

Agent Shelston IP

Pub. Number AU-A-2009228945

PCT Pub. Number WO2009/118384

Priority 08153428.1 27.03.08 EP

Filing date 26 March 2009

Wipo publication date 1 October 2009

International Classifications

C07D 239/80 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

2 September 2010 PCT application entered the National Phase

  PCT publication WO2009/118384 Priority application(s): WO2009/118384

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009228949-Polymer granules suitable as infill material for artificial turf structures

2009228943-Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors